These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1710100)

  • 1. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
    Kamel OW; Rouse RV; Warnke RA
    Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial sarcoma. An immunohistochemical study of the epithelial component.
    Jørgensen LJ; Lyon H; Myhre-Jensen O; Nordentoft A; Sneppen O
    APMIS; 1994 Mar; 102(3):191-6. PubMed ID: 7514419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma.
    Drier JK; Swanson PE; Cherwitz DL; Wick MR
    Arch Pathol Lab Med; 1987 May; 111(5):447-52. PubMed ID: 2436593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing patterns and re-distribution of antigen in poorly differentiated carcinomas: its implications in tumour diagnosis.
    Pervez S; Hasan SH; Aijaz F; Aziz SA; Amirali Y; Shaikh H
    Indian J Pathol Microbiol; 1998 Jan; 41(1):55-66. PubMed ID: 9581078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.
    Miettinen M
    Arch Pathol Lab Med; 1988 Jun; 112(6):637-40. PubMed ID: 2454091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
    Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of monoclonal antibodies to the epithelial membrane antigen in the diagnosis of human tumors].
    Delektorskaia VV; Ermilova VD; Baryshnikov AIu; Raĭkhlin NT
    Vopr Onkol; 1992; 38(5):562-71. PubMed ID: 1300755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
    Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
    Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epithelial membrane antigen in lymphosarcoma cells (immunomorphologic study)].
    Smirnov AV; Probatova NA; Sholokhova EN; Petsko AA
    Arkh Patol; 1992; 54(2):10-7. PubMed ID: 1524498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical study of tissues from clinically normal dogs and of neoplasms, using keratin monoclonal antibodies.
    Sandusky GE; Wightman KA; Carlton WW
    Am J Vet Res; 1991 Apr; 52(4):613-8. PubMed ID: 1711298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningiomas: immunohistochemical analysis of 26 cases].
    Pérez-Guiones Bacete M; Cerda-Nicolás M; Piquer J; Barcia-Mariño C
    Arch Neurobiol (Madr); 1992; 55(2):43-9. PubMed ID: 1377465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
    Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
    Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
    Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.
    Peltonen J; Jaakkola S; Lebwohl M; Renvall S; Risteli L; Virtanen I; Uitto J
    Lab Invest; 1988 Dec; 59(6):760-71. PubMed ID: 2462129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation.
    Gilcrease MZ; Delgado R; Albores-Saavedra J
    Arch Pathol Lab Med; 1998 Oct; 122(10):907-11. PubMed ID: 9786352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.